scholarly article | Q13442814 |
P2093 | author name string | Hahn YS | |
Kittlesen DJ | |||
Large MK | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
viral persistence | Q44134905 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 931-938 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence | |
P478 | volume | 162 |
Q27472875 | Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. |
Q34885791 | Activation of common antiviral pathways can potentiate inflammatory responses to septic shock |
Q40386139 | Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction |
Q27485145 | Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions |
Q30435498 | Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model |
Q27487966 | Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness |
Q34162421 | Complement and viral pathogenesis |
Q36328978 | Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes |
Q27469759 | Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus |
Q37297666 | Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma |
Q26784265 | Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection |
Q64375243 | Detection of Antigen-Specific CD8 T Cells in the Livers of HCV Core Transgenic Mice |
Q34489553 | Detection of Hepatitis B and C Viruses in Almost All Hepatocytes by Modified PCR-BasedIn SituHybridization |
Q27487006 | Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein |
Q30433630 | Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. |
Q39951846 | Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepatoma cells |
Q27486399 | Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals |
Q35963200 | Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors |
Q33607229 | Expression of hepatitis C virus core protein in hepatocytes does not modulate proliferation or apoptosis of CD8+ T cells |
Q33206994 | Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells |
Q30411437 | Extracellular HCV-core protein induces an immature regulatory phenotype in NK cells: implications for outcome of acute infection |
Q27485419 | Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses |
Q27001610 | Hepatitis C virus and vaccine development |
Q33869825 | Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection |
Q40976402 | Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses |
Q34647482 | Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein |
Q27472895 | Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model |
Q47266339 | Hepatitis C virus core protein reduces CD8+ T-cell proliferation, perforin production and degranulation but increases STAT5 activation. |
Q27469813 | Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta |
Q27488899 | Hepatitis C virus core proteins derived from different quasispecies of genotype 1b inhibit the growth of Chang liver cells |
Q27472836 | Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity |
Q43077728 | Immune tolerance in liver disease |
Q34532114 | Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver |
Q24290542 | Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation |
Q27469747 | Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation |
Q30438106 | Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system |
Q39514441 | Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection |
Q47752721 | Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. |
Q27469798 | Noncytopathic Bovine Viral Diarrhea Virus Inhibits Double-Stranded RNA-Induced Apoptosis and Interferon Synthesis |
Q27469952 | Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients |
Q27485755 | Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization |
Q41306822 | Potential Role of Hepatitis C Virus Alternate Reading Frame Protein in Negative Regulation of T-Bet Gene Expression |
Q27488288 | Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. |
Q27478031 | Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes |
Q27472767 | SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function |
Q41899846 | Schistosoma infection inhibits cellular immune responses to core HCV peptides. |
Q41438942 | TBX21 polymorphisms are associated with virus persistence in hepatitis C virus infection patients from a high-risk Chinese population |
Q64086690 | The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response |
Q36218266 | The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region |
Q35122636 | The hepatitis C virus persistence: how to evade the immune system? |
Q27469762 | Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein |
Q57037255 | Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria Meningitidis Serogroup B: Potent Inducer of the Murine Immune System |
Q27477668 | Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity |
Q22305922 | Vaccination for hepatitis C virus: closing in on an evasive target |
Q27472920 | Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C |
Search more.